November 9, 2020

10 Nov 20 | IL | Prestige BioPharma, Teva Israel | Prestige BioPharma and Teva Israel announce they have entered into an exclusive partnership and supply agreement for Prestige's Tuznue® (trastuzumab biosimilar) in Israel. Under the agreement, Prestige is responsi...

20 Oct 20 | All | Celltrion | The American Journal of Managed Care reported a new study indicates Celltrion's rituximab biosimilar CT-P10 could lower costs and expand patient access to biologic therapy for primary Sjogren syndrome.

20 Oct 20 | EG | Sandoz | Daily News E...

August 23, 2020

24 Nov 20 | EU | The EMA approves Pfizer's Nyvepria® (biosimilar pegfilgrastim).

19 Aug 20 | CA | Sandoz | Sandoz Canada announces it has entered an agreement with the Pan-Canadian Pharmaceutical Alliance (pCPA) regarding biosimilar medicines Ziextenzo® (biosimilar pegf...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags